Mumbai (Maharashtra) [India], September 22: Flagship event unites India’s leading researchers, digital transformation champions, and life sciences innovators
Revvity Signals Software have announced the return of NEXUS India. This premier user conference will be held on October 6, 2026 in Mumbai and will focus on discussing the challenges, opportunities, insights and best practices impacting the Indian market.
Now in its 4th year, NEXUS India has become an essential event for India’s R&D leaders and digital transformation pioneers. The conference continues Revvity Signals’ mission of “Sharing Knowledge and Shaping the Future” by bringing together industry experts to explore the evolving landscape of pharmaceutical, biotech, and chemical research.
The day-long agenda will feature a mix of keynote, partner and insightful customer presentations, interactive panel discussions and substantial networking opportunities. Highlights include:
Keynote
David Gosalvez, Chief Strategy Officer, Revvity Signals Software
Speakers
Ankit Mittal, R&D Head, Aarti Industries
Tushar Zade, Chief Transformation Office, Granules India Limited
Srihari Pabbaraja, Principal Scientist, Indian Institute of Chemical Technology, Hyderabad
Devdutt Shastri, Product Head, Scitara
Panel discussions
Driving Digital Transformation in R&D – Panelists from : Lupin, Cipla, PIHS, APSL and Sai Lifescience
Accelerating Innovation through Agile R&D Practices – Panelists from : Zydus, UPL, CDRI, PI and APSL
“NEXUS India brings together industry experts and members of our customer community to explore the latest trends in digital transformation and what’s next for innovation in R&D. NEXUS India has established itself as a must-attend event for the Indian research community and we look forwards to collaborating with our customers to share knowledge and shape the future of R&D”, Kapil Aggarwal, Regional VP of Sales (India & South Asia), Revvity Signals Software.
Registration is now open. For more information and to register, visit NEXUS India 2026.
About Revvity Signals
Revvity Signals Software delivers AI-powered solutions that accelerate R&D and enable data-driven innovation. At the core of our portfolio is Signals One ™, complemented by Signals Notebook ™, Signals Synergy ™, Signals BioDesign ™, Signals Xynthetica ™, ChemDraw ®, and Spotfire®. Together, these solutions empower scientists with predictive analytics, seamless collaboration, and advanced visualization capabilities to accelerate scientific discovery and development. Trusted by leading pharmaceutical and biotechnology organizations worldwide, Revvity Signals helps transform data into actionable insights across the research lifecycle.
If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.
